- News article -

Customer success-story: Optomed secured 1,97 M€ EU funding for Smartscope-X – affordable, accessible and automatic screening for diabetic retinopathy

12 Oct 2017

In May, the Finnish medical technology company Optomed was granted 1,97 M€ from Horizon 2020 SME Phase 2 instrument under the topic Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well. The funding will help Optomed make their product Smartscope-X the leading solution for diabetic retinopathy screening, supporting the company’s vision to provide affordable eye screenings to everyone.

Diabetic retinopathy is the most frequent cause of preventable blindness in working-aged adults, affecting people with all types of diabetes. Visual impairment and blindness caused by diabetic retinopathy can be prevented through early and effective screening. Currently, screening is costly, time-consuming and needs to be done by an ophthalmologist. Optomed’s solution will allow patients to do the screenings automatically and get the diagnosis in real-time.

Optomed’s fully automated diabetic retinopathy screening solution consists of three main components: a low-cost handheld camera, an automated screening algorithm and a cloud service for eyeground images. As a low-cost and portable solution, Smartscope-X can also provide access to screening for example in developing countries.

Spinverse supported Optomed in project preparation, including help in defining the scope, matching the call and assisting in writing the proposal. After a positive decision from the EU Commission in May 2017, Spinverse supported Optomed in the project negotiation phase.

“The cooperation with Spinverse worked well. The applicant always has the main responsibility during the application process, but the support from Spinverse and their expertise on the application process helped us achieve the desired outcome,” says Seppo Kopsala, CEO of Optomed.

The project officially began in August. Currently, Optomed is working on product development related to the integration between the camera and the software as well as choosing subcontractors for the server solution. Next steps towards the commercialization of Smartscope-X include several clinical tests and commercial pilots in target countries during 2018–2019.

What can you achieve with EU funding? See how we have helped companies create success stories and  contact us to discuss your options.

Photo credit: Optomed

- News -

Relevant posts

Public Funding Spinverse News

Economic growth needs innovation and long-term projects — where is the needed public funding?

18 Sep 2020

The Finnish economic success has been based on high-quality education and research. However, Finnish compani...

Public Funding Horizon Europe

Latest news about Horizon Europe and other growth opportunities beyond 2020

16 Sep 2020

Horizon Europe, the EU’s next framework programme for research and innovation, is approaching fast after t...

ecosystem Our People Spinverse News

A must-read: Ecosystem Handbook - The art of leading and creating impact

9 Sep 2020

In today’s rapidly changing world, very few organizations or people can make it alone. At best, orchestrat...

ICT Public Funding innovation ecosystem

Spinverse helped ELISE project to gain 12 M€ funding – project aims to make Europe powerhouse of AI

4 Sep 2020

The goal of the European multi-disciplinary ELISE project, recently funded with 12 M€ by the European Comm...

Client News SME EIC Accelerator

Revolutionary microphone technology from Norway

25 Aug 2020

Spinverse recently helped the Norwegian start-up sensiBel in securing the 2.5 M€ grant and 4.2 M€ equity...

Our People Spinverse News

Celebrating success: promotions and a new face in the Sustainable Industries team

24 Aug 2020

When our customers succeed, we succeed. So do our employees. The new promotions in the Sustainable Industrie...